Flavaglines Target Primitive Leukemia Cells and Enhance Anti-Leukemia Drug Activity

Leukemia - United Kingdom
doi 10.1038/leu.2014.93
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

ABCB1 Modulation Does Not Circumvent Drug Extrusion From Primitive Leukemic Progenitor Cells and May Preferentially Target Residual Normal Cells in Acute Myelogenous Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2006English

DOCK2: A Novel FLT3/ITD Leukemia Drug Target

Oncotarget
Oncology
2017English

Target Acquisition and Acute Promyelocytic Leukemia

Journal of Clinical Investigation
Medicine
1999English

Cranberry A-Type Proanthocyanidins Selectively Target Acute Myeloid Leukemia Cells

Blood advances
Hematology
2019English

Anti-Cancer Activity of Vitamin-C Against Leukemia: A Review

International Journal of Trend in Scientific Research and Development
2018English

Off-Target Based Drug Repurposing Opportunities for Tivantinib in Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2019English

Cinnamon Effectively Inhibits the Activity of Leukemia Stem Cells

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2016English

Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide

Cancer Research
Cancer ResearchOncology
2012English

Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy